ArriVent BioPharma, Correlations
| AVBP Stock | 18.28 0.71 3.74% |
The current 90-days correlation between ArriVent BioPharma, and Vinci Partners Investments is -0.14 (i.e., Good diversification). The correlation of ArriVent BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
ArriVent BioPharma, Correlation With Market
Weak diversification
The correlation between ArriVent BioPharma, Common and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ArriVent BioPharma, Common and DJI in the same portfolio, assuming nothing else is changed.
ArriVent |
Moving together with ArriVent Stock
| 0.69 | SCLX | Scilex Holding | PairCorr |
| 0.77 | CMND | Clearmind Medicine Common | PairCorr |
| 0.65 | MLSS | Milestone Scientific Earnings Call Tomorrow | PairCorr |
| 0.61 | WMT | Walmart | PairCorr |
| 0.71 | HD | Home Depot | PairCorr |
| 0.63 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
Moving against ArriVent Stock
| 0.61 | LUCD | Lucid Diagnostics | PairCorr |
| 0.39 | JNJ | Johnson Johnson | PairCorr |
| 0.35 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.34 | T | ATT Inc Aggressive Push | PairCorr |
Related Correlations Analysis
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | DWWEF | ||
| 0.0 | 0.44 | -0.45 | 0.37 | 0.25 | 0.24 | PRMB | ||
| 0.0 | 0.44 | -0.21 | 0.31 | 0.26 | 0.11 | VINP | ||
| 0.0 | -0.45 | -0.21 | -0.54 | -0.27 | -0.69 | MGPI | ||
| 0.0 | 0.37 | 0.31 | -0.54 | 0.79 | 0.57 | WM | ||
| 0.0 | 0.25 | 0.26 | -0.27 | 0.79 | 0.27 | PFLT | ||
| 0.0 | 0.24 | 0.11 | -0.69 | 0.57 | 0.27 | CRBBF | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ArriVent Stock performing well and ArriVent BioPharma, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ArriVent BioPharma,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DWWEF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PRMB | 1.29 | 0.16 | 0.09 | 0.28 | 1.56 | 3.30 | 9.97 | |||
| VINP | 1.31 | (0.01) | 0.00 | 0.03 | 0.00 | 2.66 | 5.72 | |||
| MGPI | 1.77 | (0.51) | 0.00 | (0.72) | 0.00 | 3.24 | 12.11 | |||
| WM | 0.73 | 0.17 | 0.18 | 0.34 | 0.67 | 1.57 | 8.07 | |||
| PFLT | 0.64 | 0.14 | 0.15 | 0.26 | 0.70 | 1.45 | 4.56 | |||
| CRBBF | 0.48 | 0.11 | 0.06 | 1.13 | 0.52 | 1.77 | 5.42 |
ArriVent BioPharma, Corporate Executives
Elected by the shareholders, the ArriVent BioPharma,'s board of directors comprises two types of representatives: ArriVent BioPharma, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ArriVent. The board's role is to monitor ArriVent BioPharma,'s management team and ensure that shareholders' interests are well served. ArriVent BioPharma,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ArriVent BioPharma,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Winston MBA | CFO Treasurer | Profile | |
| Robin MA | CoFounder COO | Profile |